Abstract
Background: Accumulating evidence indicates that various adipokines released from adipose tissue have been involved in abnormal insulin signalling in obesity and type 2 diabetes. However, it is not entirely clear whether these alterations in serum adipocyte concentrations are already present in the pre-diabetic state. The present study was designed to test the hypothesis that elevated levels of serum lepin an index of insulin sensitivity is independently associated with insulinemic indices among different subgroups of prediabetes. Materials: Under an observational cross-sectional design a total of 116 Control subjects (M/F, 58/58) and 99 prediabetic subjects (55/44) consisting of 49 Impaired Fasting Glucose (IFG) and 50 Impaired Glucose Tolerance (IGT) were investigated. Serum glucose was measured by glucose-oxidase method. Serum insulin and leptin were measured by ELISA techniques. Insulin secretory function (HOMA%B), insulin sensitivity (HOMA%S) and Homeostasis Model Assessment-insulin resistance (HOMA-IR) were calculated from Homeostasis Model Assessment (HOMA). Results: Compared to the Control, IFG and IGT subjects had significantly higher levels of serum leptin (ng/mL) (p<0.001) and HOMA-IR (p=0.001) respectively. However, compared to their Control counterparts, IFG and IGT subjects had significantly lower levels of HOMA%B (p=0.001) and HOMA%S (p=0.010). On binary logistic regression analysis, serum leptin (OR (95% CI): 1.074 (1.019-1.131), p=0.007) and reduced HOMA%S (OR (95% CI): 0.972 (0.950-0.995), p=0.015) were found to be significant determinants of IGT group after adjusting the effects of WC and TG. In the same analysis, serum leptin (1.109 (1.054-1.167), p<0.001) and reduced HOMA%B (0.966 (0.951-0.981), p<0.001) were found to be significant predictors of IFG group after adjusting the effects of WC and TG. Conclusion: Elevated levels of serum leptin may have an association with the state of IFG and IGT of prediabetes and this association, in turn, is mediated by insulin secretory dysfunction and reduced insulin sensitivity during this disorder.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.